Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-367-3 | CAS number: 640-67-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Solubility in Water: 285-370 mg/L at 20°C
Solubility in n-Octanol: closely to 0 g/L
log Pow: << 0
Acute oral toxicity: LD50: >2000 mg/kg b.w., no lethality up to the highest dose tested
Acute dermal toxicity: LD50 >2000 mg/kg b.w., no lethality up to the highest dose tested
Skin corrosion/irritation: not corrosive, not irritant
Eye corrosion/irritation: not corrosive, not irritant
Skin sensitisation: not skin sensitizing
Repeated dose toxicity: NOAEL: 1000 mg/kg b.w., no adverse effects up to the highest dose tested (28-d Study, Reproduction/Developmental Screening Test)
Genotoxicity: negative (AMES, HPRT, in vitro CA), Cytotoxicity: yes
Reproductive Toxicity (Fertility and Developmental Toxicity): NOAEL: 1000 mg/kg b.w. no adverse effects up to the highest dose tested (Reproduction/Developmental Screening Test)
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Toxicokinetic behavior (absorption - distribution - metabolism - excretion) has not been investigated experimentally. Thus the discussion is based on the findings in several toxicity studies together with the physico-chemical properties of the substance.
Available single and repeated dose toxicity studies didn't reveal any adverse effects after oral or dermal exposure. In particular no signs of toxic properties specific for Manganese and its salts (Mn) or for Oxalate compounds (Ox) such as Neurotoxicity (Mn) or Nephrotoxicity (Ox), or lethality (Oxalic acid, in acute toxicity studies) were observed in any of the available studies comprising macroscopic and microscopic examinations of kidneys, clinical chemistry and blood parameters and clinical observations (daily, weekly and during the functional observational battery).
Studies primarily aiming at local effects (skin irritation, acute dermal toxicity, eye irritation, skin sensitization) didn't reveal signs of relevant interaction with living tissues or skin absorption.
In vitro studies for mutagenicity came out with negative results (Ames, HPRT, CA) with and without metabolic activation. However, some cytotoxicity exists (HPRT, CA) at a similar extent, when Chinese Hamster Cells were incubated with and without metabolic activation (HPRT, Pre-Test Toxicity).
Analyses of physico-chemical properties yield a relatively low solubility in water (285-370 mg/L at 20°C) as compared to Manganese Chloride (739 g/L), Manganese Nitrate (1390 g/L), Manganese Sulfate (629 g/L), Oxalyc Acid (108 g/L), Potassium Oxalate (364 g/L) or Sodium Oxalate (34.1 g/L). In n-octanol, Manganese Oxalate was practically insoluble (closely 0 g/L). The logPow was calculated to be << 0.
From this one can infer that Manganese Oxalate:
- is practically nontoxic after acute and repeated exposure, and/or- is not bioavailable in relevant quantities after oral or dermal exposure,
- is not metabolized or hydrolyzed to toxic degradation products,
- is nontoxic to bacteria but toxic to mammalian cells when tested in vitro, however this is not an issue in vivo,
- undergoes no shift of cell toxicity when incubated with metabolic activation, meaning that Manganese Oxalate didn't decompose to metabolites of higher or lower cell toxicity,
- has no potential for bioaccumulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
